BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 23440340)

  • 1. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
    Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
    Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
    Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
    Croker AK; Allan AL
    Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis.
    Sun S; Wang Z
    Biochem Biophys Res Commun; 2010 Jun; 396(4):843-8. PubMed ID: 20450887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 3A1 is robustly upregulated in gastric cancer stem-like cells and associated with tumorigenesis.
    Wu D; Mou YP; Chen K; Cai JQ; Zhou YC; Pan Y; Xu XW; Zhou W; Gao JQ; Chen DW; Zhang RC
    Int J Oncol; 2016 Aug; 49(2):611-22. PubMed ID: 27279633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
    Wang L; Park P; Zhang H; La Marca F; Lin CY
    Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer.
    Zhi QM; Chen XH; Ji J; Zhang JN; Li JF; Cai Q; Liu BY; Gu QL; Zhu ZG; Yu YY
    Biomed Pharmacother; 2011 Oct; 65(7):509-15. PubMed ID: 21996439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
    Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
    Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
    Chen X; Lingala S; Khoobyari S; Nolta J; Zern MA; Wu J
    J Hepatol; 2011 Oct; 55(4):838-45. PubMed ID: 21334406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
    Huang CP; Tsai MF; Chang TH; Tang WC; Chen SY; Lai HH; Lin TY; Yang JC; Yang PC; Shih JY; Lin SB
    Cancer Lett; 2013 Jan; 328(1):144-51. PubMed ID: 22935675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.
    Moreb JS; Zucali JR; Ostmark B; Benson NA
    Cytometry B Clin Cytom; 2007 Jul; 72(4):281-9. PubMed ID: 17111384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Medicine-Based Approach to Model Patterns of Chemoresistance and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids.
    Raghavan S; Mehta P; Ward MR; Bregenzer ME; Fleck EMA; Tan L; McLean K; Buckanovich RJ; Mehta G
    Clin Cancer Res; 2017 Nov; 23(22):6934-6945. PubMed ID: 28814433
    [No Abstract]   [Full Text] [Related]  

  • 20. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.